BMS-955176 TFA - CAS 2097784-79-5

GSK3532795 is an orally active inhibitor of HIV-1 maturation. GSK3532795 combines broad coverage of polymorphic viruses (EC50: 15 nM toward a panel of common polymorphisms representative of 96.5% HIV-1 subtype B virus) with a favorable pharmacokinetic profile in preclinical species.

Others, HIV Protease

Microbiology/Virology, Proteases/Proteasome, Others

2097700

C44H64N2O8S

781.06

OC(=O)C(O)=O.[H][C@]12[C@@H](CC[C@@]1(CC[C@]1(C)[C@]2([H])CC[C@]2([H])[C@@]3(C)CC=C(c4ccc(cc4)C(O)=O)C(C)(C)[C@]3([H])CC[C@@]12C)NCCN1CCS(=O)(=O)CC1)C(C)=C |t:26|

-20°C

Ice Packs

Small Compound